Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)

Argentina flag Argentina · Delayed Price · Currency is ARS
1,645.00
+15.00 (0.92%)
Apr 28, 2026, 4:55 PM BRT
20.96%
Market Cap 128.80B
Revenue (ttm) 126.73B
Net Income (ttm) 3.09B
Shares Out 80.75M
EPS (ttm) 38.24
PE Ratio 53.57
Forward PE n/a
Dividend 26.89 (1.69%)
Ex-Dividend Date n/a
Volume 3,500
Average Volume 5,108
Open 1,600.00
Previous Close 1,630.00
Day's Range 1,595.00 - 1,670.00
52-Week Range 945.00 - 2,300.00
Beta -0.55
RSI 51.05
Earnings Date May 7, 2026

About BCBA:RICH

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnot... [Read more]

Sector Healthcare
Founded 1959
Employees 620
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol RICH
Full Company Profile

Financial Performance

In 2025, BCBA:RICH's revenue was 126.73 billion, an increase of 4.95% compared to the previous year's 120.75 billion. Earnings were 3.09 billion, a decrease of -90.16%.

Financial Statements

News

There is no news available yet.